Pregnancy rates were higher than might normally be expected with in vitro fertilization in the latest data for the Augment Fertility Treatment from OvaScience. But fertilization and blastocyst formation weren't particularly improved. Even the pregnancy rates don't look quite so good--when you consider all the patients who originally enrolled, noted a Leerink analyst.
Although the FDA is taking a hands-off attitude toward regulating new forms of health information technology, the Federal Trade Commission has stepped up enforcement of those app makers that make false or misleading claims.
Johnson & Johnson and Google have partnered to create new robotic-assisted surgical platforms. The deal is the latest example of Google working with a major life sciences company to make a significant technological advance.
The CEO of a publicly traded healthcare improvement alliance of 3,400 U.S. hospitals said providers need to integrate their supply chain information technology to improve upon today's fragmented and inefficient procurement process.
Orthopedics specialist Zimmer is trying to expand the market for its artificial joints by appealing to younger patients. Its strategies to do so are on display at the annual meeting of the American Academy of Orthopaedic Surgeons meeting in Las Vegas.
Olympus revealed updated cleaning instructions for duodenoscopes linked to a recent superbug outbreak at UCLA, weeks after the FDA warned that the devices' complex design may contribute to the spread of deadly bacteria and called for label modifications.
Hearing devices have not been among Medtronic's competencies--until now. The medical device giant has bought magnetic hearing implant startup Sophono for an undisclosed amount. Sophono's implant is the smallest and most effective at higher frequencies, according to the startup and Medtronic.
Stryker announced FDA clearance to use the Mako robotic surgery system for total hip replacement, as well as the launch of a new bone matrix, and spine-stabilizing cervical plate at the American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas.
Kapstone Medical has partnered with high-profile 3-D printer Materialise to launch a service specifically for medical device entrepreneurs.
Gelesis has raised $22 million to support an ongoing 6-month trial of its first-generation weight loss capsule, Gelesis100. The company recently started the study to assess its impact on body weight and glycemic control. This data could be sufficient to gain a CE mark, the company expects.
Startup TVA Medical boasted about a recent study which found that its clinical-stage device to give chronic kidney disease patients vascular access to a hemodialysis machine was successful 97% of the time.
Johnson & Johnson's DePuy Synthes unit struck a deal with medical imaging outfit Radlink to pair the company's real-time imaging technology with its hip replacement products, increasing its orthopedics clout as it looks to chart growth in the field.
Semma Therapeutics aims to provide beta cells--the pancreatic cells that produce insulin--to patients with Type 1 diabetes. If the startup can get beyond early research, an implantable device that creates insulin via these stem cell-derived beta cells could replace daily insulin injections and transform patient care.
At the American Academy of Orthopedic Surgeons meeting in Las Vegas, Zimmer touted its new training program enabling patients with its new Persona Knee System to be treated in an outpatient setting.
Edwards Lifesciences CEO Michael Mussallem testified before Congress on March 24 at a hearing entitled "Continuing America's Leadership: Advancing Research and Development for Patients." His comments focused on improving the FDA's medical device regulatory process, strengthening R&D infrastructure and continued encouragement of innovation.
Rep. Ted Lieu (D-CA) is calling for a federal investigation into the duodenoscope safety scare that has claimed lives and spread the dangerous pathogen CRE to patients across the nation. And he just sent a letter to Olympus asking the company why it did not seek FDA clearance for a 2010 redesign of its duodenoscope, if it plans to redesign the device in the future, and when the company first learned of the risk posed by the device.
Becton Dickinson is reviewing its assets now that the $12.4 billion CareFusion deal closed last week. The $30 billion medical products and diagnostics company is expected to sell the respiratory device business that was formerly part of CareFusion, Bloomberg reports.
As Big Pharma casts an eye toward med tech to diversify its offerings and capitalize on a growing market, Novartis is jumping on the bandwagon with new digital and patient monitoring devices.
Ophthalmic and surgical sutures for holding tissue together after medical procedures will no longer be made in Exeter Township, PA, thanks to the upcoming closure of the Surgical Specialties' manufacturing plant in the Philadelphia suburb. It will come at a cost of 254 jobs.
Royal Philips and Janssen Pharmaceutical have partnered in a multiyear deal to create a hand-held, blood-based diagnostic for brain disorders. The test will be based on a product that Philips is already developing, the Minicare system. The financial details of the partnership were undisclosed.